Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Response to Secukinumab in Plaque Psoriasis Using Novel Immunologic and Genetic Profiling

NCT02592018 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02592018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02592018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Response to Secukinumab in Plaque Psoriasis Using Novel Immunologic and Genetic Profiling
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis